USPTO serial 85010595
LIMERICK BIOPHARMA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- FINK, GINA M
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LIMERICK BIOPHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA
South San Francisco, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julie L. Dalke
Julie L. Dalke Latham & Watkins LLP650 Town Center Dr, 20th flCosta Mesa, CA 92626UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for the treatment of Tangiers disease, nonalcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), cystic fibrosis, human immunodeficiency virus (HIV), diabetes, hyperlipidemia, cancer, atherosclerosis, hypertension, insulin resistance, dyslipidemia, and hepatic cholestasis; pharmaceutical preparations for the treatment of the metabolic system, the central nervous system, the peripheral nervous system, the liver, the immune system, the renal system, and the cardiovascular system; pharmaceutical preparations for the treatment of metabolic diseases and disorders, infectious diseases, autoimmune diseases and disorders, inflammatory disorders, and cardiovascular disease; pharmaceutical preparations for the treatment of renal diseases, disorders and dysfunction; pharmaceutical preparations for the prevention and treatment of organ rejection; pharmaceutical preparations for use in tissue and organ transplantation, for adjuvant use in tissue and organ transplantation, for use in oncology, and for use in chemotherapy; pharmaceutical preparations and substances for the treatment of viral related diseases and disorders, and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of pain; pharmaceuticals, namely, anti-infectives, immunosuppressants, anti-inflamatories, and antivirals; analgesic pharmaceutical preparations; anti-diabetic pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 30, 2012 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 30, 2012 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 19, 2012 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 18, 2012 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 18, 2012 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 15, 2011 | EXT2 | SOU EXTENSION 2 FILED | — |
| Dec 15, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 14, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 10, 2011 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 10, 2011 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 10, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 28, 2010 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 2, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 2, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 27, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 27, 2010 | ALIE | ASSIGNED TO LIE | — |
| Sep 17, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 15, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 15, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 15, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 21, 2010 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2010 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 15, 2010 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Apr 14, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 13, 2010 | NWAP | NEW APPLICATION ENTERED | — |